Nu Holdings: ARPAC Growth Offsets Near-Term Credit Concerns, but Vigilance Required

What happened

Nu Holdings reported strong Q1 2026 results, with revenue exceeding $5B and net income of $871M, reflecting continued monetization and scaling of its digital banking platform. Average revenue per active customer (ARPAC) rose to ~$16, and Mexico achieved break-even, validating the multi-country expansion thesis. However, credit risk remains a near-term overhang: provisions surged to $1.79B (+33% QoQ), and the 15–90 day NPL ratio increased to 5.0% from 4.1% in Q4 2025, compressing risk-adjusted NIM by 100 bps to 9.5%. The market has priced in the investment-year spend, with the stock trading at 20.6x P/E and 5.2x P/B despite a 29% ROE, suggesting that investors are balancing near-term credit noise against long-term compounding potential. The key debate now is whether credit deterioration is seasonal or structural, with the next two quarters critical for confirming management's normalization narrative.

Implication

The near-term risk/reward is asymmetric: if credit costs stabilize and efficiency holds near 20%, the current valuation offers upside with a base-case target of $14, but a failure of credit normalization could drive the stock toward $9. The bull case hinges on ARPAC continuing to rise while cost-to-serve remains flat, supported by AI-native product launches and Mexico's accretive earnings. However, rising CAC and Stage 2 loan coverage indicate risk layering that could erode ROE if left unchecked. The U.S. charter remains a long-dated option with no near-term revenue impact. Position sizing should reflect the limited margin of safety, with a re-assessment window of 3–6 months tied to Q2 and Q3 2026 credit prints.

Thesis delta

The article reinforces the DeepValue report's base-case scenario of ARPAC-driven monetization outweighing credit risks, but it downplays the speed of credit deterioration. The thesis remains POTENTIAL BUY, but conviction is tempered by the fact that Q1 2026 credit data was worse than expected, and the market's tolerance for further deterioration is untested. The delta is that near-term credit normalization is no longer a base-case assumption but a critical trigger for upside; without it, the valuation multiple could compress.